Related Experiment Video
Updated: Dec 28, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.6K
Revisiting Immunotherapy: A Focus on Prostate Cancer
Ha-Ram Cha1,2, Joo Hyoung Lee1,3, Selvarangan Ponnazhagan4
1Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama.
Cancer Research
|February 19, 2020
Summary
Immunotherapy shows promise for advanced prostate cancer, particularly castration-resistant prostate cancer (CRPC). Combining tailored immunotherapies with other treatments may improve outcomes for patients.
Area of Science:
- Oncology
- Immunology
Background:
- Immunotherapy has advanced significantly, becoming crucial for advanced solid tumors.
- Prostate cancer immunotherapy has historically shown modest efficacy.
- Recent discoveries in immune mechanisms and diagnostics are reviving immunotherapy for prostate cancer.
Purpose of the Study:
- To review the progression of immunotherapy in cancer treatment.
- To focus on new discoveries and precision approaches for prostate cancer, especially CRPC.
- To discuss mechanistic insights, limitations, and future directions of prostate cancer immunotherapy.
Main Methods:
- Review of recent advancements in cancer immunotherapy.
- Analysis of immune mechanisms relevant to prostate cancer.
- Discussion of precision medicine approaches and combination therapies.
Main Results:
- Immunotherapy is increasingly effective for various solid tumors.
- Castration-resistant prostate cancer (CRPC) is a key target for novel immunotherapeutic strategies.
- Combination therapies involving immunotherapy, immune checkpoint inhibitors, and conventional treatments show potential.
Conclusions:
- Immunotherapy is a viable and evolving option for prostate cancer, especially CRPC.
- Tailored immunotherapy combined with other agents offers a promising path forward.
- Further research into mechanisms, limitations, and precise application is essential for optimizing prostate cancer immunotherapy.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Vaccines
880
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
880
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K

